SCALE-UP AND TECHNICAL TRANSFER FOR LYOPHILIZED PRODUCTS

Content Summary

Formulation and process development for injectable products are typically conducted at laboratory-scale. There are few challenges when increasing the scale of production for a solution formulation, but the challenges drastically increase when the formulation is intended for lyophilization. The process is transferred to full-scale freeze dryers that can be 10 times the size of the laboratory-scale equipment.
This whitepaper from Baxter BioPharma Solutions addresses these challenges by:
• Examining the different designs for lyophilizers
• Discussing the in-process data collected during freeze-drying
• Presenting a method of determining equipment capability and comparing data between lab-scale and full-scale equipment
Considering the differences in equipment design and capability will aid in the scale-up and technical transfer of new processes from laboratory-scale to full-scale and in transfers between manufacturing sites.

Access this content

Choose an option below

Register to access this content

Your Work Email

Your Full Name

Your Company

Your Job Function

You might also be interested in

TEMA Types Explained

Learn what TEMA standards mean for shell and tube heat exchangers—from classifications and configurations to key design codes. Discover how these guidelines ensure safety,...

Rapid Development of an Amorphous Solid Dispersion (ASD) – Nifedipine (NIF)

Amorphous solid dispersions (ASD) have long been used to increase the solubility and bi-oavailability of poorly-soluble compounds. A considerable amount of research has been...

High-Throughput Sterile Filtration of Highly Viscous Pharmaceutical Formulations

In this work, high-pressure sterile filtration (HPSF) is presented as a method to increase yield without compromise on patient safety or product quality